These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 8207960

  • 21. LGL leukemia and HTLV.
    Thomas A, Perzova R, Abbott L, Benz P, Poiesz MJ, Dube S, Loughran T, Ferrer J, Sheremata W, Glaser J, Leon-Ponte M, Poiesz BJ.
    AIDS Res Hum Retroviruses; 2010 Jan; 26(1):33-40. PubMed ID: 20047475
    [Abstract] [Full Text] [Related]

  • 22. Determination of the true prevalence of infection with the human T-cell lymphotropic viruses (HTLV-I/II) may require a combination of biomolecular and serological analyses.
    Pancake BA, Zucker-Franklin D, Marmor M, Legler PM.
    Proc Assoc Am Physicians; 1996 Nov; 108(6):444-8. PubMed ID: 8956367
    [Abstract] [Full Text] [Related]

  • 23. HTLV infection among Italian intravenous drug users and North African subjects detected by the polymerase chain reaction and serological methods.
    Colombo E, Magistrelli C, Mendozzi E, Cattaneo E, Achilli G, Ferrante P.
    J Med Virol; 1995 Sep; 47(1):10-5. PubMed ID: 8551251
    [Abstract] [Full Text] [Related]

  • 24. A new endemic focus of human T lymphotropic virus type II carriers among Orinoco natives in Colombia.
    Fujiyama C, Fujiyoshi T, Miura T, Yashiki S, Matsumoto D, Zaninovic V, Blanco O, Harrington W, Byrnes JJ, Hayami M.
    J Infect Dis; 1993 Oct; 168(4):1075-7. PubMed ID: 8376825
    [No Abstract] [Full Text] [Related]

  • 25. Typing human T-cell lymphotropic virus (HTLV-I and HTLV-II) by nested polymerase chain reaction: application to clinical specimens.
    Vallejo A, García-Sáiz A.
    J Virol Methods; 1995 Jan; 51(1):9-17. PubMed ID: 7730441
    [Abstract] [Full Text] [Related]

  • 26. Serological patterns and temporal trends of HTLV-1/2 infection in high-risk populations attending Public Health Units in São Paulo, Brazil.
    Jacob F, Santos-Fortuna E, Azevedo RS, Caterino-de-Araujo A.
    J Clin Virol; 2008 Jun; 42(2):149-55. PubMed ID: 18346935
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Type- and group-specific continuous antigenic determinants of HTLV. Use of synthetic peptides for serotyping of HTLV-I and -II infection.
    Blomberg J, Robert-Guroff M, Blattner WA, Pipkorn R.
    J Acquir Immune Defic Syndr (1988); 1992 Jun; 5(3):294-302. PubMed ID: 1371319
    [Abstract] [Full Text] [Related]

  • 29. Confirming the presence of HTLV-1 infection and the absence of HTLV-2 in blood donors from Arequipa, Peru.
    Quispe NC, Feria EB, Santos-Fortuna Ede L, Caterino-de-Araujo A.
    Rev Inst Med Trop Sao Paulo; 2009 Jun; 51(1):25-9. PubMed ID: 19229387
    [Abstract] [Full Text] [Related]

  • 30. [Sero-epidemiological study on the human T-cell leukaemia virus type I/II infection in the east coastal areas of Fujian province].
    Wang HR, Yan YS, Zhang QW, Zheng J, Liu JM, Feng YY, Wu SQ, Wu JH.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):428-30. PubMed ID: 15231172
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Detection of human T-cell leukemia/lymphoma virus, type II, in a patient with large granular lymphocyte leukemia.
    Loughran TP, Coyle T, Sherman MP, Starkebaum G, Ehrlich GD, Ruscetti FW, Poiesz BJ.
    Blood; 1992 Sep 01; 80(5):1116-9. PubMed ID: 1355373
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Is seroprevalence of HTLV-I/II among blood donors in India relevant?
    Kumar H, Gupta PK.
    Indian J Pathol Microbiol; 2006 Oct 01; 49(4):532-4. PubMed ID: 17183844
    [Abstract] [Full Text] [Related]

  • 37. Performances of HTLV serological tests in diagnosing HTLV infection in high-risk population of São Paulo, Brazil.
    Jacob F, Santos-Fortuna Ede L, Azevedo RS, Caterino-de-Araujo A.
    Rev Inst Med Trop Sao Paulo; 2007 Oct 01; 49(6):361-4. PubMed ID: 18157402
    [Abstract] [Full Text] [Related]

  • 38. Sensitivity and specificity of a recombinant transmembrane glycoprotein (rgp21)-spiked western immunoblot for serological confirmation of human T-cell lymphotropic virus type I and type II infections.
    Lal RB, Brodine S, Kazura J, Mbidde-Katonga E, Yanagihara R, Roberts C.
    J Clin Microbiol; 1992 Feb 01; 30(2):296-9. PubMed ID: 1347047
    [Abstract] [Full Text] [Related]

  • 39. Human T lymphotropic virus types I and II western blot seroindeterminate status and its association with exposure to prototype HTLV-I.
    Yao K, Hisada M, Maloney E, Yamano Y, Hanchard B, Wilks R, Rios M, Jacobson S.
    J Infect Dis; 2006 Feb 01; 193(3):427-37. PubMed ID: 16388491
    [Abstract] [Full Text] [Related]

  • 40. Diagnosis and differentiation of HTLV-I and HTLV-II infection by enzyme immunoassays using synthetic peptides.
    Viscidi RP, Hill PM, Li SJ, Cerny EH, Vlahov D, Farzadegan H, Halsey N, Kelen GD, Quinn TC.
    J Acquir Immune Defic Syndr (1988); 1991 Feb 01; 4(12):1190-8. PubMed ID: 1941526
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.